Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Patti, Francesco; Amato, Maria Pia; Bastianello, Stefano; Caniatti, Luisa; Di Monte, Elisabetta; Lijoi, Fausto; Goretti, Benedetta; Messina, Silvia; Picconi, Orietta; Tola, Maria Rosalia; Trojano, Maria

Patti, Francesco; Amato, Maria Pia; Bastianello, Stefano; Caniatti, Luisa; Di Monte, Elisabetta; Lijoi, Fausto; Goretti, Benedetta; Messina, Silvia; Picconi, Orietta; Tola, Maria Rosalia; Trojano, Maria.

Afiliação

Patti F; Multiple Sclerosis Centre Sicilia Region, First Neurology Clinic, University Hospital Catania, Via Santa Sofia 78, 95123 Catania, Italy patti@unict.it.

Ther Adv Neurol Disord ; 2(2): 67-77, 2009 Mar.

Article em En | MEDLINE | ID: mdl-21180642